Elena Garre

Goeteborg, O 41390, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs.

Tumor microenvironment-mediated interactions between macrophages and cancer cells define immunoregulatory transcriptional programs.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 18, 2026

Modeling cancer-associated fibroblast plasticity and breast cancer interactions using patient-derived scaffolds.

Modeling cancer-associated fibroblast plasticity and breast cancer interactions using patient-derived scaffolds.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 31, 2025

Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity.

Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity.

Journal: Communications biology
Published: January 08, 2025

Ribosomes modulate transcriptome abundance via generalized frameshift and out-of-frame mRNA decay.

Ribosomes modulate transcriptome abundance via generalized frameshift and out-of-frame mRNA decay.

Journal: Molecular cell
Published: February 14, 2024

Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.

Patient-derived scaffolds representing breast cancer microenvironments influence chemotherapy responses in adapted cancer cells consistent with clinical features.

Journal: Journal of translational medicine
Published: October 16, 2023

Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.

Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells.

Journal: Nature biotechnology
Published: July 14, 2023

Breast Cancer Patient-Derived Scaffolds Can Expose Unique Individual Cancer Progressing Properties of the Cancer Microenvironment Associated with Clinical Characteristics.

Breast Cancer Patient-Derived Scaffolds Can Expose Unique Individual Cancer Progressing Properties of the Cancer Microenvironment Associated with Clinical Characteristics.

Journal: Cancers
Published: March 24, 2022

Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer.

Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer.

Journal: Scientific reports
Published: March 08, 2021

Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.

Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.

Journal: Journal of cellular physiology
Published: August 11, 2020

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.

The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.

Journal: PloS one
Published: April 17, 2020

The Lsm1-7/Pat1 complex binds to stress-activated mRNAs and modulates the response to hyperosmotic shock.

The Lsm1-7/Pat1 complex binds to stress-activated mRNAs and modulates the response to hyperosmotic shock.

Journal: PLoS genetics
Published: February 15, 2018

Identification of RNA-binding proteins in exosomes capable of interacting with different types of RNA: RBP-facilitated transport of RNAs into exosomes.

Identification of RNA-binding proteins in exosomes capable of interacting with different types of RNA: RBP-facilitated transport of RNAs into exosomes.

Journal: PloS one
Published: January 17, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026